(αZ)-α-(MethoxyiMino)-N-[(5aR,6R)-1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl]-2-furanacetaMide
|
|
|
- CAS-Nr.
- 947723-87-7
- Englisch Name:
- (αZ)-α-(MethoxyiMino)-N-[(5aR,6R)-1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl]-2-furanacetaMide
- Synonyma:
- UNII-4I89S39HC0;CEFUROXIME EP IMP H;Cefuroxime EP Impurity H;(Z)-N-((5aR,6R)-1,7-dioxo;Cefuroxime Axetil EP Imp E;Cefuroxim Sodium impurity H;Cefuroxime axetil impurity E;efuroxime Axetil EP Impurity E;Cefuroxim Sodium EP Impurity H;Cefuroxime Axetil EP Impurity E
- CBNumber:
- CB62694672
- Summenformel:
- C15H13N3O6S
- Molgewicht:
- 363.35
- MOL-Datei:
- 947723-87-7.mol
|
(αZ)-α-(MethoxyiMino)-N-[(5aR,6R)-1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl]-2-furanacetaMide Eigenschaften
- Schmelzpunkt:
- >113°C (dec.)
- Dichte
- 1.77±0.1 g/cm3(Predicted)
- storage temp.
- Hygroscopic, -20°C Freezer, Under inert atmosphere
- Löslichkeit
- Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
- pka
- 8.46±0.20(Predicted)
- Aggregatzustand
- Solid
- Farbe
- White to Pale Yellow
- Stabilität:
- Hygroscopic
Sicherheit
(αZ)-α-(MethoxyiMino)-N-[(5aR,6R)-1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl]-2-furanacetaMide Chemische Eigenschaften,Einsatz,Produktion Methoden
(αZ)-α-(MethoxyiMino)-N-[(5aR,6R)-1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl]-2-furanacetaMide Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
(αZ)-α-(MethoxyiMino)-N-[(5aR,6R)-1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl]-2-furanacetaMide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 63)Lieferanten
947723-87-7()Verwandte Suche:
- (αZ)-α-(MethoxyiMino)-N-[(5aR,6R)-1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl]-2-furanacetaMide
- (Z)-N-((5aR,6R)-1,7-dioxo-1,3,4,5a,6,7-hexahydroazeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl)-2-(furan-3-yl)-2-(methoxyimino)acetamide
- Cefuroxime Axetil EP Impurity E
- Cefuroxime Impurity 8(Cefuroxime Sodium EP Impurity H)(Cefuroxime Axetil EP Impurity E)
- Cefuroxime Sodium EP Impurity H(Cefuroxime Axetil EP Impurity E)
- Cefuroxime Axetil Impurity E (EP)
- Cefuroxime axetil impurity E
- E-isomers (Cefuroxime Axetil Impurity)
- (Z)-N-((5aR,6R)-1,7-dioxo
- Cefuroxime Axetil Impurity E (EP)（Cefuroxime Lactone）
- Cefuroxime Axetil EP Imp E
- Cefuroxime Axetil EP Impurity E (Cefuroxime Sodium EP Impurity H)
- efuroxime Axetil EP Impurity E
- Cefuroxime EP Impurity H
- Cefuroxime Impurity 8/Cefuroxime EP Impurity H/(Z)-N-((5aR,6R)-1,7-dioxo-1,4,5a,6-tetrahydro-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl)-2-(furan-2-yl)-2-(methoxyimino)acetamide
- (Z)-N-(1,7-dioxo-1,4,5a,6-tetrahydro-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl)-2-(furan-2-yl)-2-(methoxyimino)acetamide
- 2-Furanacetamide, α-(methoxyimino)-N-[(5aR,6R)-1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl]-, (αZ)-
- (Z)-N-((5aR,6R)-1,7-dioxo-1,4,5a,6-tetrahydro-3H,7H-azeto[2,1-b] furo[3,4-d][1,3]thiazin-6-yl)-2-(furan-2-yl)-2-(methoxyimino)acetamid
- (Z)-N-((5aR,6R)-1,7-dioxo-1,4,5a,6-tetrahydro-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl)-2-(furan-2-yl)-2-(methoxyimino)acetamide
- UNII-4I89S39HC0
- Cefuroxim Sodium impurity H
- (5aR,6R)-6-[[(2Z)-2-(Furan-2-yl)-2-(methoxyimino)acetyl]amino]-5a,6-dihydro-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazine-1,7(4H)-dione
- (αZ)-α-(MethoxyiMino)-N-[(5aR,6R)-1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl]-2-furanacetaMide
- Methanesulfonamide,N-(7-aminophenyl)-
- (Z)-N-((5aR,6R)-1,7-Dioxo-1,3,4,5a,6,7-hexahydroazeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl)-2-(furan-2-yl)-2-(methoxyimino)acetamide (Cefuroxime Impurity)
- CEFUROXIME EP IMP H
- Cefuroxim Sodium EP Impurity H
- 947723-87-7
- 47723-87-7
- C15H10N3O6S
- Chiral Reagents, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals, Sulfur & Selenium Compounds
- ZJ
